|
|
|
|
|
|
最高研发阶段批准上市 |
|
首次获批日期2008-04-24 |
|
|
|
|
|
|
最高研发阶段批准上市 |
|
首次获批日期1999-12-29 |
Evaluation of the Efficacy and Safety of Rifaximin in Combination With N-acetylcysteine (NAC) in Adult Patients With Irritable Bowel Syndrome With Diarrhea
Randomized, prospective proof of concept, double-blind, single site clinical trial to determine the efficacy of combined rifaximin and N-acetylcysteine (NAC) therapy vs. rifaximin alone in decreasing clinical symptoms in subjects with IBS-D.
100 项与 Bausch Health Ireland Ltd. 相关的临床结果
0 项与 Bausch Health Ireland Ltd. 相关的专利(医药)
100 项与 Bausch Health Ireland Ltd. 相关的药物交易
100 项与 Bausch Health Ireland Ltd. 相关的转化医学